Sera Prognostics, Inc. (SERA)

NASDAQ: SERA · Real-Time Price · USD
2.840
+0.080 (2.90%)
At close: Jul 11, 2025, 4:00 PM
2.870
+0.030 (1.06%)
After-hours: Jul 11, 2025, 6:36 PM EDT
2.90%
Market Cap 106.99M
Revenue (ttm) 115,000
Net Income (ttm) -32.99M
Shares Out 37.67M
EPS (ttm) -0.93
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 59,437
Open 2.770
Previous Close 2.760
Day's Range 2.710 - 2.840
52-Week Range 1.370 - 9.130
Beta 0.99
Analysts n/a
Price Target n/a
Earnings Date Aug 6, 2025

About SERA

Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother’s risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction pane... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 15, 2021
Employees 64
Stock Exchange NASDAQ
Ticker Symbol SERA
Full Company Profile

Financial Performance

In 2024, Sera Prognostics's revenue was $77,000, a decrease of -74.84% compared to the previous year's $306,000. Losses were -$32.90 million, -9.23% less than in 2023.

Financial Statements

News

Sera Prognostics: PreTRM Labor Test Should Represent Advance In Risk Assessment

Sera Prognostics' PreTRM test shows strong clinical utility in reducing neonatal morbidity and NICU admissions, outperforming standard cervical length screening. The company is well-capitalized with $...

11 days ago - Seeking Alpha

SERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

SALT LAKE CITY , May 29, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarke...

6 weeks ago - PRNewsWire

SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE

SALT LAKE CITY , May 14, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarke...

2 months ago - PRNewsWire

Sera Prognostics Inc (SERA) Q1 2025 Earnings Call Transcript

Sera Prognostics Inc (NASDAQ:SERA) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Peter DeNardo - IR, CapComm Partners Zhenya Lindgardt - President, CEO & Director Austi...

2 months ago - Seeking Alpha

SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER

Industry Veteran to Spearhead Commercial Expansion, Driving Innovation and Growth at the Company SALT LAKE CITY , May 8, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SER...

2 months ago - PRNewsWire

SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

SALT LAKE CITY , May 7, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...

2 months ago - PRNewsWire

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025

SALT LAKE CITY , April 24, 2025 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biom...

2 months ago - PRNewsWire

Sera Prognostics Inc (SERA) Q4 2024 Earnings Call Transcript

Sera Prognostics Inc (NASDAQ:SERA) Q4 2024 Earnings Conference Call March 19, 2025 5:00 PM ET Company Participants Peter DeNardo - IR, CapComm Partners Evguenia Lindgardt - President, CEO & Director ...

4 months ago - Seeking Alpha

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

SALT LAKE CITY , March 19, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

4 months ago - PRNewsWire

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS

SALT LAKE CITY , March 19, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

4 months ago - PRNewsWire

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025

SALT LAKE CITY , March 11, 2025 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biom...

4 months ago - PRNewsWire

Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference

SALT LAKE CITY , Feb. 21, 2025 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bioma...

5 months ago - PRNewsWire

Sera Prognostics Announces Pricing of $50 Million Public Offering

SALT LAKE CITY , Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by provi...

5 months ago - PRNewsWire

Sera Prognostics Announces Proposed Public Offering

SALT LAKE CITY , Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by provi...

5 months ago - PRNewsWire

Sera Prognostics to Host Virtual R&D Day on January 31

Event will showcase results of Company's pivotal PRIME study and include the principal investigator SALT LAKE CITY , Jan. 27, 2025 /PRNewswire/ -- Sera Prognostics  Inc., The Pregnancy Company® (NASDA...

5 months ago - PRNewsWire

Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY , Jan. 6, 2025 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

6 months ago - PRNewsWire

Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting

SALT LAKE CITY , Dec. 4, 2024 /PRNewswire/ -- Sera Prognostics, Inc. , The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

7 months ago - PRNewsWire

Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference

SALT LAKE CITY , Dec. 2, 2024 /PRNewswire/ -- Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomark...

7 months ago - PRNewsWire

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

SALT LAKE CITY , Nov. 15, 2024 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bioma...

8 months ago - PRNewsWire

Sera Prognostics Inc (SERA) Q3 2024 Earnings Call Transcript

Sera Prognostics Inc (NASDAQ:SERA) Q3 2024 Results Conference Call November 7, 2024 5:00 PM ET Company Participants Peter DeNardo - IR Evguenia Lindgardt - President, CEO & Director Austin Aerts - Ch...

8 months ago - Seeking Alpha

SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

SALT LAKE CITY , Nov. 6, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarke...

8 months ago - PRNewsWire

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024

SALT LAKE CITY , Oct. 28, 2024 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bioma...

9 months ago - PRNewsWire

Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference

SALT LAKE CITY , Sept. 4, 2024 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bioma...

11 months ago - PRNewsWire

Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript

Sera Prognostics, Inc. (NASDAQ:SERA) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Peter DeNardo - CapComm Partners Zhenya Lindgardt - President & CEO Austin Aerts -...

1 year ago - Seeking Alpha

Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024

SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomark...

1 year ago - PRNewsWire